Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 7 studies | 37% ± 17% | |
| interneuron | 6 studies | 35% ± 19% | |
| astrocyte | 6 studies | 24% ± 6% | |
| oligodendrocyte | 6 studies | 22% ± 5% | |
| endothelial cell | 5 studies | 24% ± 13% | |
| oligodendrocyte precursor cell | 5 studies | 26% ± 9% | |
| neuron | 4 studies | 34% ± 8% | |
| glutamatergic neuron | 4 studies | 54% ± 16% | |
| GABAergic interneuron | 3 studies | 23% ± 7% | |
| granule cell | 3 studies | 20% ± 2% | |
| microglial cell | 3 studies | 20% ± 4% | |
| epithelial cell | 3 studies | 16% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 35% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2316.85 | 2642 / 2642 | 100% | 25.40 | 705 / 705 |
| thymus | 100% | 1860.71 | 653 / 653 | 100% | 14.77 | 604 / 605 |
| prostate | 100% | 2094.15 | 245 / 245 | 100% | 13.07 | 501 / 502 |
| breast | 100% | 1882.92 | 459 / 459 | 100% | 16.42 | 1114 / 1118 |
| bladder | 100% | 1760.48 | 21 / 21 | 100% | 11.94 | 502 / 504 |
| uterus | 100% | 2408.21 | 170 / 170 | 100% | 12.83 | 457 / 459 |
| lung | 100% | 1611.50 | 577 / 578 | 99% | 11.40 | 1144 / 1155 |
| pancreas | 99% | 789.23 | 325 / 328 | 99% | 12.08 | 177 / 178 |
| esophagus | 100% | 1397.76 | 1445 / 1445 | 98% | 12.25 | 180 / 183 |
| intestine | 100% | 1588.65 | 966 / 966 | 98% | 8.75 | 518 / 527 |
| kidney | 100% | 1595.40 | 89 / 89 | 98% | 16.34 | 883 / 901 |
| ovary | 100% | 2831.46 | 180 / 180 | 97% | 9.07 | 419 / 430 |
| adrenal gland | 100% | 1236.67 | 257 / 258 | 97% | 13.21 | 223 / 230 |
| stomach | 100% | 1124.12 | 359 / 359 | 97% | 8.90 | 276 / 286 |
| skin | 100% | 1529.00 | 1808 / 1809 | 95% | 12.26 | 449 / 472 |
| liver | 92% | 530.29 | 208 / 226 | 64% | 4.05 | 259 / 406 |
| adipose | 100% | 1794.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.98 | 29 / 29 |
| spleen | 100% | 2167.90 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 10.97 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.46 | 1 / 1 |
| blood vessel | 100% | 1747.79 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 827.42 | 832 / 861 | 0% | 0 | 0 / 0 |
| muscle | 95% | 562.96 | 760 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 8.26 | 73 / 80 |
| peripheral blood | 86% | 919.48 | 801 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZFP90 |
| Protein name | Zinc finger protein 90 homolog (Zfp-90) (Zinc finger protein 756) ZFP90 zinc finger protein |
| Synonyms | KIAA1954 ZNF756 |
| Description | FUNCTION: Inhibits the transcriptional repressor activity of REST by inhibiting its binding to DNA, thereby derepressing transcription of REST target genes. .; FUNCTION: [Isoform 2]: Acts as a bridge between FOXP3 and the corepressor TRIM28, and is required for the transcriptional repressor activity of FOXP3 in regulatory T-cells (Treg). . |
| Accessions | ENST00000562156.5 I3L2Q3 ENST00000570495.5 [Q8TF47-1] I3L3M0 ENST00000564323.5 ENST00000576305.5 ENST00000573685.5 ENST00000569109.5 ENST00000573113.3 ENST00000569323.5 I3L0T2 ENST00000563169.7 [Q8TF47-1] ENST00000611381.4 [Q8TF47-3] H3BMI1 ENST00000573161.1 ENST00000564558.5 I3L1L4 I3L0X7 H3BVC6 ENST00000398253.6 [Q8TF47-1] ENST00000576805.5 Q8TF47 ENST00000571382.5 J3QKQ8 ENST00000571809.5 |